Evidence map›Paper›PMID 39870737›Full record

ArticleScientific reports2025

A fractal-fractional order modeling approach to understanding stem cell-chemotherapy combinations for cancer.

Esam Y Salah, Bhausaheb Sontakke, Ahmed A Hamoud, Homan Emadifar, Atul Kumar

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esam Y SalahDepartment of Mathematics, Pratishthan College, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India.
Bhausaheb SontakkeDepartment of Mathematics, Pratishthan College, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India.
Ahmed A HamoudDepartment of Mathematics, Taiz University, Taiz, 6803, Yemen.
Homan EmadifarDepartment of Mathematics, Hamedan Branch, Islamic Azad University, Hamedan, Iran. homan_emadi@yahoo.com.
Atul KumarDepartment of Mathematics, Dayalbagh Educational Institute, Agra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main objective of this work is to study the mathematical model that combines stem cell therapy and chemotherapy for cancer cells. We study the model using the fractal fractional derivative with the Mittag-Leffler kernel. In the analytical part, we study the existence of the solution and its uniqueness, which was studied based on the fixed point theory. The equilibrium points were also studied and discussed after stem cell therapy, and the approximate solutions for the given model were obtained using the Adam Bashford method, which depends on interpolation with Lagrange polynomials. Finally, the model was simulated using the Mathematica software, and through the figures, we found that the components of the model approach the equilibrium point, which indicates the stability of the model at the equilibrium point. Also, the result of the numerical simulation and graphic for the concentration of cells over time indicate the effects of the therapies on the decay rate of tumor cells and the growth rate of effector cells to modify the cancer patient's immune system. It is worth noting that we simulated all the model components with different fractional orders, confirming the effect of stem cell therapy and chemotherapy on the cells and the decay of cancer cells.

Indexed as

Antineoplastic AgentsModels, BiologicalModels, TheoreticalNeoplasmsStem Cell TransplantationCombined Modality TherapyComputer SimulationFractalsHumansAntineoplastic AgentsAdams-Bashforth methodFractional derivativeMathematical modelMatignon criterion

Identifiers

PMID39870737
PMCPMC11772579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.